Cannabis: Medical Treatments

(asked on 30th November 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans he has to ensure the hierarchy of medicines is enforced in relation to cannabis-based medicinal products.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 9th December 2020

NHS England has disseminated resources to support clinicians and guidance on the prescribing process for cannabis-based products for medicinal use (CBPMs).

The vast majority of CBPMs are unlicensed medicines, which have not been assessed by the medicines regulator. As such these are not first line treatments and specialist doctors must take into consideration the clinical evidence base, and the guidance from the General Medical Council (GMC) on licensed, off label and unlicensed medicines and local National Health Service governance systems when making a decision to prescribe.

Reticulating Splines